Review
doi: 10.1024/0369-8394.95.3.61.
[Respiratory syncytial virus infections: measures in immunocompromised patients]
[Article in
German]
Affiliations
- PMID: 16459735
- DOI: 10.1024/0369-8394.95.3.61
Item in Clipboard
Review
[Respiratory syncytial virus infections: measures in immunocompromised patients]
[Article in
German]
Praxis (Bern 1994).
.
Abstract
RSV infections are an annually recurring problem of significant morbiditiy and mortality in the immunocompromised host, especially after lung and stem cell transplantation. The effectiveness of hygienic (isolation) and therapeutic (ribavirin, immunoglobulin, pavilizumab) measures depends of high index of suspicion and rapid diagnostic confirmation by the antigen test, PCR and/or culture. Allocation of resources require stratification of measures according to the known or estimated risk for complications.
Similar articles
-
Prophylaxis and treatment of respiratory syncytial virus in adult immunocompromised patients.Ann Pharmacother. 2012 Apr;46(4):558-66. doi: 10.1345/aph.1Q553. Epub 2012 Mar 6. Ann Pharmacother. 2012. PMID: 22395247 Review.
-
Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients.Pediatr Infect Dis J. 2007 Dec;26(12):1089-93. doi: 10.1097/INF.0b013e3181343b7e. Pediatr Infect Dis J. 2007. PMID: 18043443
-
A multi-drug regimen for respiratory syncytial virus and parainfluenza virus infections in adult lung and heart-lung transplant recipients.Transpl Infect Dis. 2010 Feb;12(1):38-44. doi: 10.1111/j.1399-3062.2009.00453.x. Epub 2009 Sep 15. Transpl Infect Dis. 2010. PMID: 19761558
-
Oral ribavirin therapy for respiratory syncytial virus infections in moderately to severely immunocompromised patients.Transpl Infect Dis. 2014 Apr;16(2):242-50. doi: 10.1111/tid.12194. Epub 2014 Mar 13. Transpl Infect Dis. 2014. PMID: 24621016
-
Management of infections caused by respiratory syncytial virus.Scand J Infect Dis. 2001;33(5):323-8. doi: 10.1080/003655401750173869. Scand J Infect Dis. 2001. PMID: 11440215 Review.
Cited by
-
Physical interventions to interrupt or reduce the spread of respiratory viruses.Cochrane Database Syst Rev. 2020 Nov 20;11(11):CD006207. doi: 10.1002/14651858.CD006207.pub5. Cochrane Database Syst Rev. 2020. Update in: Cochrane Database Syst Rev. 2023 Jan 30;1:CD006207. doi: 10.1002/14651858.CD006207.pub6. PMID: 33215698 Free PMC article. Updated.
-
Low incidence of severe respiratory syncytial virus infections in lung transplant recipients despite the absence of specific therapy.J Heart Lung Transplant. 2010 Mar;29(3):299-305. doi: 10.1016/j.healun.2009.08.012. Epub 2009 Oct 17. J Heart Lung Transplant. 2010. PMID: 19837611 Free PMC article.
-
Community-Acquired Respiratory Viruses in Transplant Patients: Diversity, Impact, Unmet Clinical Needs.Clin Microbiol Rev. 2019 Sep 11;32(4):e00042-19. doi: 10.1128/CMR.00042-19. Print 2019 Sep 18. Clin Microbiol Rev. 2019. PMID: 31511250 Free PMC article. Review.
-
Physical interventions to interrupt or reduce the spread of respiratory viruses.Cochrane Database Syst Rev. 2023 Jan 30;1(1):CD006207. doi: 10.1002/14651858.CD006207.pub6. Cochrane Database Syst Rev. 2023. PMID: 36715243 Free PMC article.
-
Physical interventions to interrupt or reduce the spread of respiratory viruses.Cochrane Database Syst Rev. 2011 Jul 6;2011(7):CD006207. doi: 10.1002/14651858.CD006207.pub4. Cochrane Database Syst Rev. 2011. Update in: Cochrane Database Syst Rev. 2020 Nov 20;11:CD006207. doi: 10.1002/14651858.CD006207.pub5. PMID: 21735402 Free PMC article. Updated.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
